| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody durability at 1 year after Sputnik V vaccination
|
Sanchez, Lautaro
|
|
|
22 |
5 |
p. 589-590
|
artikel
|
| 2 |
Applying big data to childhood vaccination in Africa
|
Bidmos, Fadil
|
|
|
22 |
5 |
p. 585
|
artikel
|
| 3 |
Assortative mixing among vaccination groups and biased estimation of reproduction numbers
|
Klaus, Colin
|
|
|
22 |
5 |
p. 579-581
|
artikel
|
| 4 |
CD24Fc: an emerging COVID-19 therapy
|
Eckhardt, Christina M
|
|
|
22 |
5 |
p. 565-567
|
artikel
|
| 5 |
Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial
|
Kumar, Deepali
|
|
|
22 |
5 |
p. 718-730
|
artikel
|
| 6 |
Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis
|
Marchello, Christian S
|
|
|
22 |
5 |
p. 692-705
|
artikel
|
| 7 |
Correction to Lancet Infect Dis 2022; published online Jan 17. https://doi.org/10.1016/S1473-3099(21)00471-0
|
|
|
|
22 |
5 |
p. e128
|
artikel
|
| 8 |
Correction to Lancet Infect Dis 2022; published online March 8. https://doi.org/10.1016/S1473-3099(21)00692-7
|
|
|
|
22 |
5 |
p. e128
|
artikel
|
| 9 |
Countries recommit to Guinea worm eradication by 2030
|
Burki, Talha
|
|
|
22 |
5 |
p. 597-598
|
artikel
|
| 10 |
COVID-19 vaccine: what are we doing and what should we do?
|
Candelli, Marcello
|
|
|
22 |
5 |
p. 569-570
|
artikel
|
| 11 |
Declining immunisation coverage in Brazil
|
Alves, Lise
|
|
|
22 |
5 |
p. 596
|
artikel
|
| 12 |
Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study
|
Tacconelli, Evelina
|
|
|
22 |
5 |
p. 731-741
|
artikel
|
| 13 |
Dynamics of humoral and T-cell immunity after three BNT162b2 vaccinations in adults older than 80 years
|
Romero-Olmedo, Addi J
|
|
|
22 |
5 |
p. 588-589
|
artikel
|
| 14 |
Effectiveness of BNT162b2 against COVID-19 in adolescents
|
Powell, Annabel A
|
|
|
22 |
5 |
p. 581-583
|
artikel
|
| 15 |
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study
|
Welker, James
|
|
|
22 |
5 |
p. 611-621
|
artikel
|
| 16 |
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
|
|
|
|
22 |
5 |
p. 622-635
|
artikel
|
| 17 |
Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial
|
de Vries, Henry J C
|
|
|
22 |
5 |
p. 706-717
|
artikel
|
| 18 |
Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study
|
Birger, Ruthie
|
|
|
22 |
5 |
p. 679-691
|
artikel
|
| 19 |
Ethiopia faces a measles outbreak amid a security crisis
|
Bagcchi, Sanjeet
|
|
|
22 |
5 |
p. 595
|
artikel
|
| 20 |
Evaluating BLOOMY and SOFA scores in hospitalised patients
|
Benzoni, Nicole
|
|
|
22 |
5 |
p. 592
|
artikel
|
| 21 |
Evaluating BLOOMY and SOFA scores in hospitalised patients – Authors' reply
|
Gladstone, Beryl P
|
|
|
22 |
5 |
p. 592-593
|
artikel
|
| 22 |
Free-living sparganosis in the lumbosacral spine with long latency
|
Liu, Jun
|
|
|
22 |
5 |
p. 742
|
artikel
|
| 23 |
Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis
|
Hart, William S
|
|
|
22 |
5 |
p. 603-610
|
artikel
|
| 24 |
Global health systems' data science approach for precision diagnosis of sepsis in early life
|
Iregbu, Kenneth
|
|
|
22 |
5 |
p. e143-e152
|
artikel
|
| 25 |
GRADE misuse in systematic reviews
|
Lv, Meng
|
|
|
22 |
5 |
p. 590-591
|
artikel
|
| 26 |
GRADE misuse in systematic reviews – Authors' reply
|
Uyttebroek, Saartje
|
|
|
22 |
5 |
p. 591-592
|
artikel
|
| 27 |
Infectious disease surveillance update
|
Islam, Tanzina
|
|
|
22 |
5 |
p. 598
|
artikel
|
| 28 |
In-hospital mortality of patients with severe bloodstream infection: only the tip of the iceberg
|
Pletz, Mathias W
|
|
|
22 |
5 |
p. 576-577
|
artikel
|
| 29 |
Is combination antiviral therapy for influenza the optimal approach?
|
Lampejo, Temi
|
|
|
22 |
5 |
p. 587-588
|
artikel
|
| 30 |
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
|
Rasmussen, Charlotte
|
|
|
22 |
5 |
p. 586-587
|
artikel
|
| 31 |
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
|
Xu, Chengchao
|
|
|
22 |
5 |
p. 585-586
|
artikel
|
| 32 |
Lien Jih-ching
|
Bagcchi, Sanjeet
|
|
|
22 |
5 |
p. 600
|
artikel
|
| 33 |
Marion Koopmans—preparing for the next pandemic
|
Kirby, Tony
|
|
|
22 |
5 |
p. 601
|
artikel
|
| 34 |
Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study
|
Chen, Yuyang
|
|
|
22 |
5 |
p. 657-667
|
artikel
|
| 35 |
Modelling vaccination to mitigate typhoid fever burden
|
Keddy, Karen H
|
|
|
22 |
5 |
p. 571-573
|
artikel
|
| 36 |
Movement dynamics: reduced dengue cases during the COVID-19 pandemic
|
Sasmono, R Tedjo
|
|
|
22 |
5 |
p. 570-571
|
artikel
|
| 37 |
Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study
|
Witte, Desiree
|
|
|
22 |
5 |
p. 668-678
|
artikel
|
| 38 |
Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy
|
Corrao, Giovanni
|
|
|
22 |
5 |
p. 649-656
|
artikel
|
| 39 |
Research in brief
|
Devi, Sharmila
|
|
|
22 |
5 |
p. 599
|
artikel
|
| 40 |
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study
|
Sridhar, Saranya
|
|
|
22 |
5 |
p. 636-648
|
artikel
|
| 41 |
Severe influenza: is there a role for antiviral combinations?
|
Sridhar, Siddharth
|
|
|
22 |
5 |
p. 574-576
|
artikel
|
| 42 |
Shortened antituberculosis therapy options for children
|
Venkatesan, Priya
|
|
|
22 |
5 |
p. 594
|
artikel
|
| 43 |
The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations
|
Goossens, Herman
|
|
|
22 |
5 |
p. e153-e158
|
artikel
|
| 44 |
Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19
|
Shapiro, Adrienne E
|
|
|
22 |
5 |
p. 567-569
|
artikel
|
| 45 |
To our friend, John
|
Walsh, Timothy R
|
|
|
22 |
5 |
p. 583-584
|
artikel
|
| 46 |
Treating pharyngeal gonorrhoea continues to remain a challenge
|
Kong, Fabian Y S
|
|
|
22 |
5 |
p. 573-574
|
artikel
|
| 47 |
Tuberculosis services disrupted by war in Ukraine
|
Holt, Ed
|
|
|
22 |
5 |
p. e129
|
artikel
|
| 48 |
Understanding how fast SARS-CoV-2 variants transmit from household studies
|
Yang, Yang
|
|
|
22 |
5 |
p. 564-565
|
artikel
|
| 49 |
Understanding the history of infectious diseases
|
Burki, Talha
|
|
|
22 |
5 |
p. 602
|
artikel
|
| 50 |
Using big data and mobile health to manage diarrhoeal disease in children in low-income and middle-income countries: societal barriers and ethical implications
|
Keddy, Karen H
|
|
|
22 |
5 |
p. e130-e142
|
artikel
|
| 51 |
War and infectious diseases: brothers in arms
|
The Lancet Infectious Diseases,
|
|
|
22 |
5 |
p. 563
|
artikel
|
| 52 |
WHO SAVE LIVES: Clean Your Hands campaign
|
Tartari, Ermira
|
|
|
22 |
5 |
p. 577-579
|
artikel
|
Tijdschrift beschrijving